R. V. Kampen

A real-world study on implementation of bevacizumab in a cohort of HER2-negative metastatic breast cancer patients: A study of the Southeast Netherlands Breast Cancer Consortium

V. Tjan-Heijnen, N. Peters, M. Joore, 2017 .

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

M. de Boer, G. Borm, V. Tjan-Heijnen, 2013, Breast Cancer Research and Treatment.

Clinical validity of tumor-in fi ltrating lymphocytes analysis in patients with triple-negative breast cancer

N. Peters, T. Smilde, A. Voogd, 2016 .

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.

M. de Boer, V. Tjan-Heijnen, N. Peters, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.

V. Tjan-Heijnen, T. Smilde, A. Voogd, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.